Investigation of the source of new testosterone production in prostate tumours that become resistant to existing hormonal (testosterone lowering and blocking) therapies
Grant number: 1024081 | Funding period: 2012 - 2015
Prostate cancer is critically dependent upon continued testosterone stimulation, even when the disease becomes resistant to existing hormonal therapies that suppress serum levels. The source of this testosterone is currently unclear. This study aims to identify the site of testosterone synthesis in patients with prostate cancer, and determine the relevance of continued testosterone signalling in patients treated with 'super castrating' hormonal therapy.
Related publications (6)
Inferring structural variant cancer cell fraction
Marek Cmero, Ke Yuan, Cheng Soon Ong, Jan Schröder, null PCAWG Evolution and Heterogeneity Working Group, Niall M Corcoran, Tony Papenfuss, Christopher M Hovens, Florian Markowetz, Geoff Macintyre, null PCAWG Consortium
We present SVclone, a computational method for inferring the cancer cell fraction of structural variant (SV) breakpoints from whol..
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction
Marcus C Hovens, Kevin Lo, Michael Kerger, John Pedersen, Timothy Nottle, Natalie Kurganovs, Andrew Ryan, Justin S Peters, Daniel Moon, Anthony J Costello, Niall M Corcoran, Matthew KH Hong
Prostate cancer displays a wide spectrum of clinical behaviour from biological indolence to rapidly lethal disease, but we remain ..
Comparing nodal versus bony metastatic spread using tumour phylogenies
Stefano Mangiola, Matthew KH Hong, Marek Cmero, Natalie Kurganovs, Andrew Ryan, Anthony J Costello, Niall M Corcoran, Geoff Macintyre, Christopher M Hovens
The role of lymph node metastases in distant prostate cancer dissemination and lethality is ill defined. Patients with metastases ..
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
Ryan Stuchbery, Geoff Macintyre, Marek Cmero, Laurence M Harewood, Justin S Peters, Anthony J Costello, Christopher M Hovens, Niall M Corcoran
BACKGROUND: Despite the importance of androgen receptor (AR) signalling to prostate cancer development, little is known about how ..
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Matthew KH Hong, Geoff Macintyre, David C Wedge, Peter Van Loo, Keval Patel, Sebastian Lunke, Ludmil B Alexandrov, Clare Sloggett, Marek Cmero, Francesco Marass, Dana Tsui, Stefano Mangiola, Andrew Lonie, Haroon Naeem, Nikhil Sapre, Pramit M Phal, Natalie Kurganovs, Xiaowen Chin, Michael Kerger, Anne Y Warren
Tumour heterogeneity in primary prostate cancer is a well-established phenomenon. However, how the subclonal diversity of tumours ..
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Ryan Stuchbery, Natalie J Kurganovs, Patrick J Mccoy, Colleen C Nelson, Vanessa M Hayes, Niall M Corcoran, Christopher M Hovens
Cancer is fundamentally a genomic disease caused by mutations or rearrangements in the DNA or epigenetic machinery of a patient. A..